Hahnfeldt P - Search Results

1

Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.

Benzekry S, Hahnfeldt P. Benzekry S, et al. Among authors: hahnfeldt p. J Theor Biol. 2013 Oct 21;335:235-44. doi: 10.1016/j.jtbi.2013.06.036. Epub 2013 Jul 11. J Theor Biol. 2013. PMID: 23850479

2

Mathematical Modeling of Tumor-Tumor Distant Interactions Supports a Systemic Control of Tumor Growth.

Benzekry S, Lamont C, Barbolosi D, Hlatky L, Hahnfeldt P. Benzekry S, et al. Among authors: hahnfeldt p. Cancer Res. 2017 Sep 15;77(18):5183-5193. doi: 10.1158/0008-5472.CAN-17-0564. Epub 2017 Jul 20. Cancer Res. 2017. PMID: 28729417 Free PMC article.

3

Proton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissue.

Wage J, Ma L, Peluso M, Lamont C, Evens AM, Hahnfeldt P, Hlatky L, Beheshti A. Wage J, et al. Among authors: hahnfeldt p. J Radiat Res. 2015 Sep;56(5):792-803. doi: 10.1093/jrr/rrv043. Epub 2015 Aug 7. J Radiat Res. 2015. PMID: 26253138 Free PMC article.

4

Therapeutic implications from sensitivity analysis of tumor angiogenesis models.

Poleszczuk J, Hahnfeldt P, Enderling H. Poleszczuk J, et al. Among authors: hahnfeldt p. PLoS One. 2015 Mar 18;10(3):e0120007. doi: 10.1371/journal.pone.0120007. eCollection 2015. PLoS One. 2015. PMID: 25785600 Free PMC article.

5

Global dormancy of metastases due to systemic inhibition of angiogenesis.

Benzekry S, Gandolfi A, Hahnfeldt P. Benzekry S, et al. Among authors: hahnfeldt p. PLoS One. 2014 Jan 21;9(1):e84249. doi: 10.1371/journal.pone.0084249. eCollection 2014. PLoS One. 2014. PMID: 24465399 Free PMC article.

6

Beyond the cancer cell: progression-level determinants highlight the multiscale nature of carcinogenesis risk.

Hlatky L, Hahnfeldt P. Hlatky L, et al. Among authors: hahnfeldt p. Cancer Res. 2014 Feb 1;74(3):659-64. doi: 10.1158/0008-5472.CAN-13-2508. Epub 2013 Nov 22. Cancer Res. 2014. PMID: 24272486 Review.

7

An integrated multidisciplinary model describing initiation of cancer and the Warburg hypothesis.

Rietman EA, Friesen DE, Hahnfeldt P, Gatenby R, Hlatky L, Tuszynski JA. Rietman EA, et al. Among authors: hahnfeldt p. Theor Biol Med Model. 2013 Jun 10;10:39. doi: 10.1186/1742-4682-10-39. Theor Biol Med Model. 2013. PMID: 23758735 Free PMC article.

8

Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics.

Hahnfeldt P, Hlatky L, Klement GL. Hahnfeldt P, et al. Cancer Res. 2013 May 15;73(10):2949-54. doi: 10.1158/0008-5472.CAN-12-3807. Epub 2013 Mar 14. Cancer Res. 2013. PMID: 23492368 Free PMC article.

9

Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation.

Wilkie KP, Hahnfeldt P. Wilkie KP, et al. Among authors: hahnfeldt p. Bull Math Biol. 2017 Jun;79(6):1426-1448. doi: 10.1007/s11538-017-0291-4. Epub 2017 Jun 5. Bull Math Biol. 2017. PMID: 28585066 Free PMC article.

10

The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked?

Kareva I, Hahnfeldt P. Kareva I, et al. Among authors: hahnfeldt p. Cancer Res. 2013 May 1;73(9):2737-42. doi: 10.1158/0008-5472.CAN-12-3696. Epub 2013 Feb 19. Cancer Res. 2013. PMID: 23423980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results